Susan Altschuller | Alexion Pharmaceuticals, Inc. |
Ludwig N. Hantson | Alexion Pharmaceuticals, Inc. |
Paul J. Clancy | Alexion Pharmaceuticals, Inc. |
John J. Orloff | Alexion Pharmaceuticals, Inc. |
Brian Goff | Alexion Pharmaceuticals, Inc. |
Geoffrey C. Porges | Leerink Partners LLC |
Matthew K. Harrison | Morgan Stanley & Co. LLC |
Geoff Meacham | Barclays Capital, Inc. |
Joshua Schimmer | Evercore ISI |
Robyn Karnauskas | Citigroup Global Markets, Inc. |
Christopher J. Raymond | Piper Jaffray & Co. |
Paul Matteis | Stifel Financial Corp. |
Phil Nadeau | Cowen & Co. LLC |
Terence Flynn | Goldman Sachs & Co. LLC |
Laura Chico | Raymond James & Associates, Inc. |
Ying Huang | Bank of America Merrill Lynch |
Anupam Rama | JPMorgan Securities LLC |
Good morning, and welcome to the Alexion Pharmaceuticals, Incorporated Third Quarter 2018 Results Conference Call. Today's call is being recorded.
For opening remarks and introductions, I would now like to turn the call over to Susan Altschuller. [Technical Difficulty] (00:17-00:28)
Thank you, Crystal.